Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-26

Clinical Trial Update: MSCs for the Treatment of Burn Wounds [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating mesenchymal stem cells for treatment of burn wounds, including second- and third-degree burns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Instituto Venezolano de Investigaciones Cientificas | Conditions: Burn Wound, Second- or Third-degree Burn | Phase 1, Phase 2 | Status: UNKNOWN